View item

Stroke Foundation - ‘Return to life, return to work’ clinical research grants for 2019
Sponsor: Medical Research Future Fund (MRFF) 		Closing Date: 30-Nov-2018
Supported by the Australian Government's Medical Research Future Fund (MRFF), the Stroke Foundation is facilitating a targeted clinical research investment in recovery for working age survivors of chronic stroke through two dedicated research grants funded from 2019-2021:

1. Clinical Trial: Perispinal Etanercept (PSE) as a therapy promoting recovery after chronic stroke for younger stroke survivors in Australia (particularly those of working age).
2. Clinical Trial: Return to work (RTW) for younger stroke survivors in Australia.

The ‘Return to life, return to work' initiative will fund projects aimed at developing innovative recovery and rehabilitation clinical interventions for younger stroke survivors in Australia - an emerging priority area with unmet needs. These projects will continue to accelerate important neurological research and support Australian researchers to be at the forefront of finding solutions for stroke recovery.

Eligibility
• Researchers of any career stage may apply.
• The research team must be Australian led.
• International trial sites may be included in the project.
• Lead applicants who have (or have not) previously received a research grant from the Stroke Foundation are eligible.

Funding
Clinical Trial: Perispinal Etanercept (PSE) as a therapy promoting recovery after chronic stroke for younger stroke survivors in Australia (particularly those of working age)
A 2.5-year grant of up to $750,000 to support a robust, independent, multi-centred clinical trial of Perispinal Etanercept (PSE) in Australian stroke survivors of working age is funded. Annual release of funding will be according to the Recipient's yearly budgets as submitted in the application, conditional to: no more than $300,000 budgeted per annum.

What may be funded?
• The research plan must follow the specifications detailed in Section 7 of the application procedure for clinical trials.
• A significant part of the research must be carried out in Australia.
• Preference will be given to those applications including some, or all, of the following criteria:
- Have significant community engagement
- Have international collaboration, particularly with funding contribution.
- Applications that follow the CONSORT criteria and TIDieR guidelines.
• The grant is to be used for direct research costs such as equipment and, support personnel such as research assistants or casual help, or other assistance necessary for a specific project.

What is not funded?
• This funding does not cover institutional fees; infrastructure costs; overheads; PhD stipends.

Clinical Trial: Return to work for younger stroke survivors in Australia
A 2.5-year grant of up to $250,000 to support a clinical trial of an intervention designed to improve return to work rates for younger stroke survivors in Australia is funded. Annual release of funding will be according to the Recipient's yearly budgets as submitted in the application, conditional to: no more than $100,000 budgeted per annum.

What may be funded?
• The research plan must follow the specifications detailed in Section 7 of the application procedure for clinical trials.
• A significant part of the research must be carried out in Australia.
• Preference will be given to those applications including some, or all, of the following criteria:
- Innovative projects.
- Applications that follow the CONSORT criteria and TIDieR guidelines.
• The grant is to be used for equipment, support personnel such as research assistants or casual help, or other assistance necessary for a specific project.

What is not funded?
This funding does not cover institutional fees; infrastructure costs; overheads; PhD stipends.

Please see https://strokefoundation.org.au/What-we-do/Research/Research-grants/Clinical-trials for further information, the application forms and the ‘Return to life, return to work’ Clinical Research Grants application guide, which incorporates the application procedure. Submission of applications is via email to research@strokefoundation.org.au by the closing date and time.

Key Dates
Full Applications due to UQR&I: 19 November 2018
Applications close with Stroke Foundation: 30 November 2018, 5pm AEDT

For UQR&I internal review and feedback, email your application and completed Funding Application Coversheet to your UQR&I Office of Sponsored Research RAO.
Website: http://strokefoundation.org.au/What-we-do/Research/Research-grants/Clinical-trials

Return